Both in vivo and in vitro experiments indicate that GIT promotes Bax expression, activities of cleaved Caspase-3 and PARP, and enhances LC3II and P-AMPK expressions in lung cancer cells through the AMPK and AKT signaling pathways, thereby initiating autophagy. Here, CASP3 is linked to lung carcinoma.